Pluri Inc.

$2.60+3.17%(+$0.08)
TickerSpark Score
45/100
Weak
20
Valuation
45
Profitability
90
Growth
40
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PLUR research report →

52-Week Range10% of range
Low $2.22
Current $2.60
High $5.96

Companypluri-biotech.com

Pluri Inc. , a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease.

CEO
Yaacov Yanay
IPO
2003
Employees
106
HQ
Haifa, IL

Price Chart

-46.61% · this period
$5.79$4.16$2.52May 20Nov 18May 20

Valuation

Market Cap
$23.38M
P/E
-1.00
P/S
21.67
P/B
-1.41
EV/EBITDA
-2.01
Div Yield
0.00%

Profitability

Gross Margin
19.00%
Op Margin
-2412.14%
Net Margin
-2424.75%
ROE
203.55%
ROIC
-117.79%

Growth & Income

Revenue
$1.34M · 309.82%
Net Income
$-22,583,000 · -8.11%
EPS
$-3.56 · 10.78%
Op Income
$-22,176,000
FCF YoY
-8.10%

Performance & Tape

52W High
$5.96
52W Low
$2.22
50D MA
$3.33
200D MA
$3.79
Beta
0.75
Avg Volume
7.70K

Get TickerSpark's AI analysis on PLUR

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Apr 21, 26Manieu Alexandre Weinsteinother312,500
Apr 21, 26Manieu Alexandre Weinsteinother312,500
Mar 31, 26Manieu Alexandre Weinsteinother312,500
Mar 31, 26Manieu Alexandre Weinsteinother312,500
Dec 8, 25Manieu Alexandre Weinsteinother625,000
Dec 8, 25Manieu Alexandre Weinsteinother625,000
Dec 4, 25Manieu Alexandre Weinsteinother519
Dec 4, 25Ajchenbaum Eitanother668
Dec 4, 25YANAY YAKYother6,588
Dec 4, 25Levi Rami Avrahamother653

Our PLUR Coverage

We haven't published any research on PLUR yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate PLUR Report →

Similar Companies